| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $106.6B | $107.4B | $109.1B | $106.0B | $93.6B | $23.4B | $23.0B | $22.8B |
| Cost of Revenue | $76.5B | $77.7B | $82.2B | $75.0B | $66.2B | $17.1B | $16.9B | $16.8B |
| Gross Profit | — | — | — | — | — | — | — | $6.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $22.0B | $21.6B | $20.7B | $19.8B | $18.6B | $4.5B | $4.4B | $4.2B |
| Operating Income | $5.6B | $5.7B | $3.8B | $8.9B | $6.5B | $1.2B | $1.1B | — |
| Net Income | $4.1B | $4.1B | $2.8B | — | — | — | — | — |
| EPS (Basic) | $8.89 | $8.96 | $6.02 | $14.23 | $8.72 | $1.65 | $1.54 | $2.03 |
| EPS (Diluted) | $8.86 | $8.94 | $5.98 | $14.10 | $8.64 | $1.63 | $1.52 | $2.02 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $57.8B | $55.4B | $53.3B | $53.8B | $51.2B | $42.8B | $41.3B | $39.0B |
| Current Assets | $19.5B | $17.5B | $17.8B | $21.6B | $20.8B | $12.9B | $12.5B | $12.6B |
| Cash & Equivalents | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.4B | — |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $20.8B | $19.3B | $19.5B | $21.7B | $20.1B | $14.5B | $15.0B | $13.2B |
| Stockholders' Equity | $14.7B | $13.4B | $11.2B | $12.8B | $14.4B | $11.8B | $11.3B | $11.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.4B | $8.6B | $4.0B | $8.6B | $10.5B | $7.1B | $6.0B | $6.9B |
| Investing Cash Flow | $-2.9B | $-4.8B | $-5.5B | $-3.2B | $-2.6B | $-2.9B | $-3.4B | $-3.1B |
| Capital Expenditures | $2.9B | $4.8B | $5.5B | $3.5B | $2.6B | $3.0B | $3.5B | $2.5B |
| Financing Cash Flow | $-3.5B | $-2.3B | $-2.2B | $-8.1B | $-2.0B | $-3.2B | $-3.6B | $-3.7B |